NCT01552369: A reported trial by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT01552369 |
|---|---|
| Title | Prophylaxis Versus Preemptive Therapy for the Prevention of CMV in High-Risk R-D+ Liver Transplant Recipients |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Oct. 29, 2012 |
| Completion date | June 22, 2018 |
| Required reporting date | June 22, 2019, midnight |
| Actual reporting date | June 13, 2019 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |